Majid and Lynn Jafar honoured by UMass Chan Medical School for advancing medical research

The University of Massachusetts Chan Medical School has honoured Majid Jafar, CEO of Crescent Petroleum, and his wife Lynn Barghout Jafar, co-founders of the Loulou Foundation, for their work in advancing medical research and innovation and for supporting children with special needs through the High Hopes Therapy Center in the UAE.

The honorary doctorate degrees, presented at the university’s 2025 Commencement ceremony by Chancellor Michael Collins, highlight their role in accelerating scientific and therapeutic progress in the field of rare diseases — an area that remains significantly underdiagnosed and underserved, with the vast majority of conditions still lacking approved treatments. More than 350 million people are affected by rare diseases worldwide, with 70 per cent of them children. While over 7,000 rare diseases have been identified, 95 per cent still lack approved treatments.

Majid Jafar comments: “We are deeply honoured by this recognition from UMass Chan Medical School. It affirms what can be achieved when purpose-driven collaboration meets urgency — especially in the field of rare diseases, where so many families are still waiting for new treatments. The UAE has long recognised the importance of medical innovation, and we remain committed to contributing to this global effort to improve children’s lives and accelerate meaningful change.”

Umass Chan Medical School is among the leading medical schools in the United States and last year entered into a strategic partnership agreement with Mohammed bin Rashid University (MBRU) of Medicine and Health Sciences in Dubai. The commencement ceremony also conferred honorary doctorate degrees on Dr Marcia McNutt, President of the U.S. National Academy of Sciences, and Dr Carolyn Clancy, Assistant Under Secretary for Health at the US Veterans Health Administration.

Lynn Barghout Jafar, co-founder of the Loulou Foundation and Founder of the High Hopes Therapy Center in Dubai, adds: “When our own daughter was diagnosed with a rare disease, what began as a personal journey quickly became a global mission to connect families and scientists in the pursuit of answers. We are grateful to be part of a growing community that is transforming the future of rare disease research through science, collaboration, and hope."